Danaher Corporation $DHR Shares Sold by Toth Financial Advisory Corp

Toth Financial Advisory Corp lessened its holdings in Danaher Corporation (NYSE:DHRFree Report) by 32.4% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 5,442 shares of the conglomerate’s stock after selling 2,611 shares during the quarter. Toth Financial Advisory Corp’s holdings in Danaher were worth $1,036,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also modified their holdings of DHR. Mufg Securities Americas Inc. lifted its holdings in shares of Danaher by 9.0% in the 2nd quarter. Mufg Securities Americas Inc. now owns 18,972 shares of the conglomerate’s stock valued at $3,614,000 after buying an additional 1,563 shares during the period. Nissay Asset Management Corp Japan raised its position in Danaher by 4.4% in the second quarter. Nissay Asset Management Corp Japan now owns 84,803 shares of the conglomerate’s stock worth $16,153,000 after acquiring an additional 3,596 shares in the last quarter. Hsbc Holdings PLC raised its position in Danaher by 5.3% in the second quarter. Hsbc Holdings PLC now owns 1,443,380 shares of the conglomerate’s stock worth $274,998,000 after acquiring an additional 73,115 shares in the last quarter. Tandem Capital Management Corp ADV lifted its holdings in Danaher by 4.2% in the second quarter. Tandem Capital Management Corp ADV now owns 16,039 shares of the conglomerate’s stock valued at $3,055,000 after acquiring an additional 640 shares during the period. Finally, Field & Main Bank purchased a new stake in shares of Danaher during the 2nd quarter worth $29,000. 79.05% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of equities analysts have recently issued reports on DHR shares. HSBC cut their price target on shares of Danaher from $270.00 to $230.00 and set a “buy” rating for the company in a report on Wednesday, June 3rd. Piper Sandler began coverage on shares of Danaher in a research report on Thursday, June 11th. They set a “neutral” rating and a $200.00 price target for the company. DZ Bank assumed coverage on Danaher in a research note on Wednesday, June 3rd. They set a “buy” rating and a $210.00 price target on the stock. Evercore restated an “outperform” rating and issued a $230.00 price target on shares of Danaher in a report on Monday, July 6th. Finally, Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and issued a $240.00 price objective on shares of Danaher in a research note on Wednesday, July 22nd. One investment analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, Danaher presently has a consensus rating of “Moderate Buy” and an average target price of $228.91.

Get Our Latest Stock Report on DHR

Danaher Trading Up 0.3%

Shares of Danaher stock opened at $216.41 on Friday. Danaher Corporation has a 1 year low of $160.93 and a 1 year high of $242.80. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.65 and a quick ratio of 1.25. The business has a 50 day moving average price of $199.46 and a 200 day moving average price of $192.52. The company has a market capitalization of $152.13 billion, a P/E ratio of 38.44, a P/E/G ratio of 2.69 and a beta of 0.78.

Danaher (NYSE:DHRGet Free Report) last announced its earnings results on Monday, July 20th. The conglomerate reported $1.94 EPS for the quarter, beating analysts’ consensus estimates of $1.85 by $0.09. The firm had revenue of $6.26 billion for the quarter, compared to analysts’ expectations of $6.12 billion. Danaher had a return on equity of 11.04% and a net margin of 15.95%.Danaher’s quarterly revenue was up 5.5% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.77 EPS. Sell-side analysts anticipate that Danaher Corporation will post 8.53 EPS for the current fiscal year.

Danaher Profile

(Free Report)

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

Featured Articles

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHRFree Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.